Text mining driven drug-drug interaction detection

Proceedings - 2013 IEEE International Conference on Bioinformatics and Biomedicine, IEEE BIBM 2013

Volumn , Issue , 2013, Pages 349-354

  Yan, Su ^a   Jiang, Xiaoqian ^b   Chen, Ying ^a  

^a IBM ALMADEN RESEARCH CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84894596756     PISSN: None     EISSN: None     Source Type: Conference Proceeding    
DOI: 10.1109/BIBM.2013.6732517     Document Type: Conference Paper

References (24)

1. R. S. Obach, "Drug-drug interactions: an important negative attribute in drugs." Drugs of Today, vol. 39, no. 5, pp. 301-338, 2003.
2. P. A. Pham, "Drug-drug interaction programs in clinical practice." Clinical Pharmacology & Therapeutics, vol. 83, no. 3, pp. 396-398, 2008.
3. L. Zhang, Y. D. Zhang, P. Zhao, and S.-M. Huang, "Predicting drug-drug interactions: an FDA perspective." The AAPS journal, vol. 11, no. 2, pp. 300-306, 2009.
4. L. M. Almond, J. Yang, M. Jamei, G. T. Tucker, and A. Rostami-Hodjegan, "Towards a quantitative framework for the prediction of DDIs arising from cytochrome p450 induction," Current Drug Metabolism, vol. 10, no. 4, pp. 420-432.
5. C. Lu, P. Hatsis, C. Berg, F. Lee, and S. Balani, "Prediction of pharmacokinetic drug-drug interactions using human hepatocyte suspension in plasma and cytochrome p450 phenotypic data. ii. in vitro-in vivo correlation with ketoconazole." Drug Metab Dispos, vol. 36, no. 7, pp. 1255-60, 2008.
6. F. Dexter, "Statistical analysis of drug interactions in anesthesia." Journal of Theoretical Biology, vol. 172, no. 4, pp. 305-314, 1995.
7. T. Tachibana, M. Kato, T. Watanabe, T. Mitsui, and Y. Sugiyama, "Method for predicting the risk of drug-drug interactions involving inhibition of intestinal CYP3A4 and P-glycoprotein." Xenobiotica the Fate of Foreign Compounds in Biological Systems, vol. 39, no. 6, pp. 430-43, 2009.
8. M. Imaura, Y. Ohno, K. Nakajima, and H. Suzuki, "Clinically significant drug-drug and drug-food interactions associated with calcium channel blockers," Clinical Calcium, vol. 15, no. 10, pp. 1709-1716, 2005.
9. N. P. Tatonetti, G. H. H. Fernald, and R. B. Altman, "A novel signal detection algorithm for identifying hidden drug-drug interactions in adverse event reports." Journal of the American Medical Informatics Association : JAMIA, vol. 19, no. 1, pp. 79-85, Jan. 2012.
10. E. van Puijenbroek, A. Egberts, E. Heerdink, and H. Leufkens, "Detecting drug-drug interactions using a database for spontaneous adverse drug reactions: an example with diuretics and non-steroidal anti-inflammatory drugs." Eur J Clin Pharmacol, vol. 56, no. 9-10, pp. 733-8, 2000.
11. G. N. Norén, R. Sundberg, A. Bate, and I. R. Edwards, "A statistical methodology for drug-drug interaction surveillance." Statistics in Medicine, vol. 27, no. 16, pp. 3057-3070, 2008.
12. T.-M. Hu and W. L. Hayton, "Architecture of the drug-drug interaction network." Journal of Clinical Pharmacy and Therapeutics, vol. 36, no. 2, pp. 135-143, 2011.
13. L. Tari, S. Anwar, S. Liang, J. Cai, and C. Baral, "Discovering drug-drug interactions: a text-mining and reasoning approach based on properties of drug metabolism." Bioinformatics, vol. 26, no. 18, pp. i547-53, 2010.
14. M. Takarabe, D. Shigemizu, M. Kotera, S. Goto, and M. Kanehisa, "Characterization and classification of adverse drug interactions." Genome Informatics International Conference on Genome Informatics, vol. 22, no. Japic Id, pp. 167-175, 2010.
15. N. P. Tatonetti, G. H. Fernald, and R. B. Altman, "A novel signal detection algorithm for identifying hidden drug-drug interactions in adverse event reports." Journal of the American Medical Informatics Association, vol. 2, pp. 79-85, 2011.
16. B. Percha, Y. Garten, and R. B. Altman, "Discovery and explanation of drug-drug interactions via text mining." Pacific Symposium On Biocomputing, no. Ddi, pp. 410-21, 2012.
17. J. Huang, C. Niu, C. D. Green, L. Yang, H. Mei, and J.-D. D. Han, "Systematic prediction of pharmacodynamic drug-drug interactions through protein-protein-interaction network." PLoS computational biology, vol. 9, no. 3, pp. e1 002 998+, Mar. 2013.
18. S. Vilar, R. Harpaz, E. Uriarte, L. Santana, R. Rabadan, and C. Friedman, "Drug-drug interaction through molecular structure similarity analysis," JAMIA, vol. 19, no. 6, pp. 1066-1074, 2012.
19. S. Vilar, E. Uriarte, L. Santana, N. P. Tatonetti, and C. Friedman, "Detection of Drug-Drug Interactions by Modeling Interaction Profile Fingerprints," PLoS ONE, vol. 8, p. 58321, Mar. 2013.
20. J. D. Lafferty, A. McCallum, and F. C. N. Pereira, "Conditional random fields: Probabilistic models for segmenting and labeling sequence data," in Proceedings of the Eighteenth International Conference on Machine Learning, 2001, pp. 282-289.
21. M. Hewett, D. E. Oliver, D. L. Rubin, K. L. Easton, J. M. Stuart, R. B. Altman, and Teri, "Pharmgkb: the pharmacogenetics knowledge base," Nucleic Acids Research, vol. 30, pp. 163-165, 2002.
22. B. Smith, M. Ashburner, C. Rosse, J. Bard, W. Bug, W. Ceusters, L. Goldberg, K. Eilbeck, A. Ireland, C. Mungall, N. Leontis, P. Rocca-Serra, A. Ruttenberg, S. Sansone, R. Scheuermann, N. Shah, P. Whetzel, and S. Lewis, "The obo foundry: coordinated evolution of ontologies to support biomedical data integration." Nat Biotechnol, vol. 25, no. 11, pp. 1251-5, 2007.
23. D. M. Blei, A. Y. Ng, and M. I. Jordan, "Latent dirichlet allocation," the Journal of Machine Learning Research, vol. 3, pp. 993-1022, 2003.
24. M. Rosen-Zvi, C. Chemudugunta, T. Griffiths, P. Smyth, and M. Steyvers, "Learning author-topic models from text corpora," ACM Trans. Inf. Syst., vol. 28, no. 1, pp. 4:1-4:38, Jan. 2010.